Status:
RECRUITING
Resistance Exercise in Patients With Ocular Melanoma
Lead Sponsor:
University of Valencia
Conditions:
Ocular Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Choroidal melanoma (CM) is one of the most common intraocular cancers worldwide. During treatment with episcleral brachytherapy, patients require a week of hospitalization in isolation. The primary ai...
Detailed Description
Candidates of the present study will be adults with CM diagnose and treated with plaque brachytherapy undergoing in "Hospital Universitari i Politècnic La Fe" (Valencia). All the participants will be ...
Eligibility Criteria
Inclusion
- Adults with Choroidal Melanoma diagnose and treated with plaque brachytherapy undergoing in "Hospital Universitari i Politècnic La Fe" (Valencia).
Exclusion
- Present a health status that forbids high intensity resistance training.
- Have any unsteady cardiac illness.
- Have serious metabolic disorder.
- Have any important orthopaedic disorder impeding exercise.
Key Trial Info
Start Date :
February 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06970236
Start Date
February 1 2025
End Date
December 1 2026
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari i Politècnic de La Fe
Valencia, Spain, Spain, 46026